TGFβ1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells

Anticancer Research

Volumn 21, Issue 2 A, 2001, Pages 1207-1212

  Totth A ^a   Sebestyen A ^a   Barna, G ^a   Nagy, K ^a   Gondor A ^a   Bocsi, J ^a   Mihalik, R ^a   Petak I ^a   Houghton, J ^a   Kopper, L ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Apoptosis; Caspases; Death receptors; Lymphoma; Mitochondria; TGF 1

Indexed keywords

CASPASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASE 3; CASPASES; HUMANS; LYMPHOCYTES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR DECOY RECEPTORS;

EID: 0035002231     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. The mitochondrial death/life regulator in apoptosis and necrosis
2. Mitochondria and apoptosis
3. Apoptosis signaling in lymphocytes
4. Regulation of immune responses by TGF-β
5. The role of TGFβ in growth, differentiation and maturation of B lymphocytes
6. TGF-βI and cyclic AMP promote apoptosis in resting human B lymphocytes
7. Transforming growth factor beta as endogenous growth factor inhibitor of chronic lymphocytic leukemia B cells
8. Loss of functional cell surface transforming beta (TGF-β) type I receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia
9. Resistance to TGF-β1 correlates with a reduction of TGF-β type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines
10. Controlling TGF-beta signalling
11. Signaling inputs converge on nuclear effectors in TGF-beta signaling
12. Loss of transforming growth factor beta I regulatory activity in human non-Hodgkin lymphomas
13. Expression of transforming growth factor-beta 1 in human non-Hodgkin's lymphoma xenografts
14. New in vitro line from human (B) non-Hodgkin lymphoma
15. Features of apoptotic cells measured by flow cytometry
16. Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrozobenzamide
17. Regulation of antibody production and class switching by TGF-beta
18. Transforming growth factor-beta 1 cooperates with anti-immunoglobulin for the induction of apoptosis in groupI (biopsy-like) Burkitt lymphoma cell line
19. L escape negative selection and are tolerized by clonal anergy and receptor editing
20. L downregulation
21. Immune escape mechanism of Hodgkin disease
22. Aberrant responses of human lymphocytic neoplasms to cytokine regulation
23. Mechanism that contribute to the development of lymphoid malignancies: Roles for genetic alterations and cytokine production
24. Molecular mechanism of inactivation of TGF-beta receptors during carcinogenesis
25. Transforming growth factor and multidrug resistance in chronic lymphocytic leukemia
26. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-x1, NF-kappa B, and p53
27. NFkappaB-mediated up-regulation of bcl-x and bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
28. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor R1/Fas death
29. The transforming growth factor β-inducible transcription factor, TIEG1, mediates apoptosis through oxidative stress
30. A mechanism of suppression of TGF-β/Smad signaling by Nf-kB/RelA
31. Allday apoptosis induced by TGF-β1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent
32. Role of transforming growth factor-β signaling in Cancer